Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Pfizer’s cut-price version of Avastin wins EU panel greenlight

expressbpdDecember 18, 2018

Tag: Pfizer , Avastin , cancer , EMA , biosimilar

PharmaSources Customer Service